Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

Saved in:
Bibliographic Details
Published inEuropean journal of neurology Vol. 29; no. 1; pp. e7 - e8
Main Authors Jakubikova, Michala, Tyblova, Michaela, Tesar, Adam, Magda, Horakova, Daniela, Vlazna, Irena, Rysankova, Iveta, Novakova, Kristyna, Doleckova, Pavel, Dusek, Jiri, Pitha, Stanislav, Vohanka, Josef, Bednarik
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.01.2022
John Wiley and Sons Inc
Subjects
COVID-19
Humans
Letters to the Editor
Muscle and MNJ Disorders
Myasthenia
Myasthenia gravis
Myasthenia Gravis - complications
Neuromuscular junctions
SARS-CoV-2
Thymectomy
Online AccessGet full text

Cover

More Information
Bibliography:Horakova Magda, Vlazna Daniela, Vohanka Stanislav and Bednarik Josef are members of the European Reference Network for Neuromuscular Diseases ‐ Project ID No. 870177.
Jakubikova Michala, Tyblova Michaela and Tesar Adam all contributed equally.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Correspondence-1
ObjectType-Commentary-2
content type line 23
ISSN:1351-5101
1468-1331
1468-1331
DOI:10.1111/ene.15158